No Controversy Here
While controversy exists in the USA concerning research with embryonic stem cells, everyone agrees that using adult stem cells are appropriate and efficacious. Rabin Medical Center has made a major breakthrough in applying adult stem cells to treat Parkinson's disease by developing NurOwn, a technology that generates neuron-like cells derived from human bone marrow. Using the patient's own bone marrow to supply dopamineproducing cells circumvents problems of immunity and compatibility. Credit for the discovery goes to Prof. Eldad Melamed, Director of Neurology at the Rabin Medical Center and member of the Michael J. Fox Foundation for Parkinson's Research, together with Dr. Daniel Offen, Director of Laboratory of Neurosciences at Rabin Medical Center, and Dr. Yosef Levy. Commercialized by Brainstorm Cell Therapeutics based in Tel Aviv, NurOwn actually produces the missing chemical that enables restoration of motor movement.
Related Articles
iPad Catheterization Application Used for the First Time at Rabin Medical Center
A new advanced technology has been developed for the first time worldwide, at Rabin Medical Center's Invasive Cardiology Institute, where all pertinent information collected during the cardiac catheterization procedure is sent directly to an iPad.
The Earlier the Better: Probing Malignancies in Newborns
Building on their established international partnership, GE
Healthcare and Rabin Medical Center are developing innovative
products and working on creative medical solutions to facilitate
the early diagnosis of medical problems in pregnant women
and their fetuses.
Male fetuses are more trouble
Judy Siegel-Itzkovich, THE JERUSALEM POST
It isn't an "old wives' tale" that carrying a male fetus is more "troublesome" than carrying a female fetus, according to research encompassing over 66,000 women who gave birth at the Rabin Medical Center (RMC) in Petah Tikva between 1995 and 2006.